GEHLSEN KURT R 4
4 · MAXIM PHARMACEUTICALS INC · Filed Nov 24, 2003
Insider Transaction Report
Form 4
GEHLSEN KURT R
Chief Scientific Officer
Transactions
- Award
Option to Purchase (NSO)
2003-11-20$6.72/sh+25,000$168,000→ 25,000 totalExercise: $6.72Exp: 2013-11-20→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]F1 1/4 of the shares vest annually beginning one year after the transaction date.